# Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatase Inhibitor-induced Arthralgia (AIA): a Phase 2, Randomized, Monocentric, taVNS Versus Sham, Double Blind

> **NCT07575750** · NA · NOT_YET_RECRUITING · sponsor: **Institut Cancerologie de l'Ouest** · enrollment: 60 (estimated)

## Conditions studied

- Breast Cancer
- Aromatase Inhibitor-induced Arthralgia

## Interventions

- **DEVICE:** Active taVNS (TENS ECO Plus)
- **DEVICE:** Sham taVNS (TENS ECO Plus)

## Key facts

- **NCT ID:** NCT07575750
- **Lead sponsor:** Institut Cancerologie de l'Ouest
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2028-11
- **Final completion:** 2028-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07575750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07575750, "Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatase Inhibitor-induced Arthralgia (AIA): a Phase 2, Randomized, Monocentric, taVNS Versus Sham, Double Blind". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07575750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*